Novo Nordisk’s Introduction of AI-Powered Research  Novo Nordisk has revealed intentions to establish an AI-based research facility in London, specifically geared towards advancing drug discovery operations. Strategic Location: King’s Cross Knowledge Quarter The new hub, set within the King’s Cross Knowledge Quarter (KQ), signifies a strategic step towards harnessing artificial intelligence for progressive pharmaceutical research....